Steady state [Regulatives / Guidelines]

posted by kumarnaidu – Mumbai, India, 2014-12-10 12:15 (3798 d 12:07 ago) – Posting: # 14044
Views: 14,804

Hi All,
I am little bit confused with this statement.
In all other cases, where accumulation is likely (AUC(0-τ) after the first dose covers less than 90% of mean AUC(0-∞)) a multiple dose study is required. Generally, steady-state studies should be performed under the conditions concerning concomitant food intake recommended in the SmPC for the originator product.

If for any drug concomittant food intake is reccomended and it shows no accumulation (AUC(0-τ) after the first dose covers less than 90% of mean AUC(0-∞)) then in that case should we go for steady state or not?:confused:

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
69 visitors (0 registered, 69 guests [including 7 identified bots]).
Forum time: 01:23 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5